(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

Danish biotech Bavarian Nordic said on Friday the order book for delivery of its vaccine for mpox and smallpox in 2025 ...

Bavarian Nordic has already secured a sizeable portion of revenue for 2025 through orders for its mpox/smallpox vaccine, but ...

Vaccine maker Bavarian Nordic expects the incoming Trump administration to boost biodefence funding despite the nomination of ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

Discover more on Bavarian Nordic's vaccine sales decline, diversification strategy, and strong Travel Health segment, ...

Danish biotech Bavarian Nordic said on Friday the order book for delivery of its vaccine for mpox and smallpox in 2025 ...

Danish biotech Bavarian Nordic anticipates a boost in biodefense funding by the incoming U.S. administration despite concerns ...

Bavarian Nordic AS (BVNKF) reports robust travel health business growth and strategic advancements in vaccine launches amid ...

Bavarian Nordic AS (OCSE:BAVA) is set to release its Q3 2024 earnings on Nov 15, 2024. The consensus estimate for Q3 2024 ...

Bavarian Nordic A/S ( (BVNRY) ) has released its Q3 earnings. Here is a breakdown of the information Bavarian Nordic A/S presented to its ...

COPENHAGEN, Denmark, November 15, 2024 – (OMX: BAVA) announced today its interim financial results for the first nine months ...